Association of serum neurofilament light chain levels at disease onset with disability worsening in patients with a first demyelinating multiple sclerosis event not treated …
…, JE Martínez-Rodríguez, L Brieva… - JAMA …, 2023 - jamanetwork.com
Importance The value of serum neurofilament light chain (sNfL) levels for predicting long-term
disability in patients with multiple sclerosis (MS) remains controversial. Objective To …
disability in patients with multiple sclerosis (MS) remains controversial. Objective To …
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis
…, J Rio, P Díaz-Villoslada, L Brieva… - American Journal …, 2000 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Various authors have developed criteria to classify MR
imaging findings that suggest the possibility of multiple sclerosis. The purpose of this study was …
imaging findings that suggest the possibility of multiple sclerosis. The purpose of this study was …
Cerebellar ataxia with anti–glutamic acid decarboxylase antibodies: study of 14 patients
…, A Saiz, B Giometto, A Vincent, L Brieva… - Archives of …, 2001 - jamanetwork.com
Background Antibodies to glutamic acid decarboxylase (GAD-Ab) are described in patients
with insulin-dependent (type 1) diabetes mellitus (IDDM), in stiff-man syndrome, and, recently…
with insulin-dependent (type 1) diabetes mellitus (IDDM), in stiff-man syndrome, and, recently…
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone
…, E Julià, J Río, M Tintoré, L Brieva… - Multiple Sclerosis …, 2006 - journals.sagepub.com
Background and objective Fatigue is one of the most limiting symptoms in multiple sclerosis
(MS) and the mechanisms underlying its origin are poorly understood. Our aim was to test …
(MS) and the mechanisms underlying its origin are poorly understood. Our aim was to test …
Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus
…, FJJ Villaverde, ÁP Sempere, L Brieva… - Neuroimmunology & …, 2016 - AAN Enterprises
Objective: To (1) determine the value of the recently proposed criteria of neuromyelitis optica
(NMO) spectrum disorder (NMOSD) that unify patients with NMO and those with limited …
(NMO) spectrum disorder (NMOSD) that unify patients with NMO and those with limited …
Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism
Metabolomic and lipidomic analyses have been used for the profiling of neurodegenerative
processes, both in targeted and untargeted approaches. In this work we have applied these …
processes, both in targeted and untargeted approaches. In this work we have applied these …
Epidemiology of NMOSD in Catalonia: influence of the new 2015 criteria in incidence and prevalence estimates
…, R Pelayo, L Gubieras, L Brieva… - Multiple Sclerosis …, 2018 - journals.sagepub.com
Background: Population-based studies on neuromyelitis optica spectrum disorders (NMOSD)
are limited, and it is unclear whether the rates have changed with the implementation of …
are limited, and it is unclear whether the rates have changed with the implementation of …
Effect of ocrelizumab in blood leukocytes of patients with primary progressive MS
…, E Carreón-Guarnizo, Y Aladro, L Brieva… - Neurology …, 2021 - AAN Enterprises
Objective To analyze the changes induced by ocrelizumab in blood immune cells of
patients with primary progressive MS (PPMS). Methods In this multicenter prospective study …
patients with primary progressive MS (PPMS). Methods In this multicenter prospective study …
[HTML][HTML] A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease …
…, E Ruiz-Fernández, E San Pedro-Murillo, L Brieva - Journal of …, 2023 - Springer
Background Most people with Multiple Sclerosis (pwMS) are subjected to immunomodulatory
disease-modifying treatments (DMTs). As a result, immune responses to COVID-19 …
disease-modifying treatments (DMTs). As a result, immune responses to COVID-19 …
The California, ABCD, and unified ABCD2 risk scores and the presence of acute ischemic lesions on diffusion-weighted imaging in TIA patients
…, A Quílez, G Pinol-Ripoll, J Sanahuja, L Brieva… - Stroke, 2009 - Am Heart Assoc
Background and Purpose— Some clinical models, like California ABCD and unified ABCD2
scores, are now available to predict the early risk of stroke after a TIA. Despite the transitivity …
scores, are now available to predict the early risk of stroke after a TIA. Despite the transitivity …